BIOXYTRAN, INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Bioxytran, Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q4 2024.
  • Bioxytran, Inc Common Stock, Shares, Issued for the quarter ending December 31, 2024 was 86.8M shares, a 40% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 86.8M -57.9M -40% Dec 31, 2024 10-K 2025-04-03
Q3 2024 82.2M -62.1M -43% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 177M +45.4M +34.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 173M +49.5M +40.1% Mar 31, 2024 10-Q 2024-04-19
Q4 2023 145M +21.3M +17.3% Dec 31, 2023 10-K 2025-04-03
Q3 2023 144M +21.3M +17.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 132M +132M Jun 30, 2023 10-Q 2023-07-31
Q1 2023 124M +12.7M +11.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 123M +12.5M +11.3% Dec 31, 2022 10-K/A 2025-01-13
Q3 2022 123M +13.1M +12% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 0 -110M -100% Jun 30, 2022 10-Q 2023-07-31
Q1 2022 111M +10.2M +10.1% Mar 31, 2022 10-Q 2023-05-12
Q4 2021 111M +13.4M +13.7% Dec 31, 2021 10-K 2023-03-31
Q3 2021 110M +12.7M +13.1% Sep 30, 2021 10-Q 2021-11-17
Q2 2021 110M +12.8M +13.2% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 101M +12.4M +14.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 97.5M +11M +12.7% Dec 31, 2020 10-K 2022-04-11
Q3 2020 97.2M +11.9M +13.9% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 97M +11.9M +14% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 88.2M +3.13M +3.68% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 86.5M +1.37M +1.61% Dec 31, 2019 10-K 2021-04-09
Q3 2019 85.3M +203K +0.24% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 85.1M -25.3M -22.9% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 85.1M -20.3M -19.3% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 85.1M 0 0% Dec 31, 2018 10-K 2020-03-18
Q3 2018 85.1M +50.2M +144% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 110M +75.5M +216% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 105M +81.6M +343% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 85.1M +56.9M +202% Dec 31, 2017 10-K 2019-03-13
Q3 2017 34.9M +3.75M +12% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 34.9M +6.75M +24% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 23.8M -250K -1.04% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 28.2M 0 0% Dec 31, 2016 10-K 2018-04-02
Q3 2016 31.2M +18.9M +153% Sep 30, 2016 10-Q 2016-12-09
Q2 2016 28.2M +15.9M +129% Jun 30, 2016 10-Q 2016-09-20
Q1 2016 24.1M +18.3M +314% Mar 31, 2016 10-Q 2016-09-20
Q4 2015 28.2M +22.3M +384% Dec 31, 2015 10-K 2017-03-31
Q3 2015 12.3M -279M -95.8% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 12.3M -174M -93.4% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 5.82M -185M -96.9% Mar 31, 2015 10-Q 2015-05-19
Q4 2014 5.82M +1.94M +50% Dec 31, 2014 10-K 2016-09-20
Q3 2014 291M +97M +50% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 186M -8.03M -4.14% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 190M +6.99M +3.81% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 3.88M -157M -97.6% Dec 31, 2013 10-K 2015-04-10
Q3 2013 194M +52.8M +37.4% Sep 30, 2013 10-Q 2013-11-18
Q2 2013 194M +65.1M +50.6% Jun 30, 2013 10-Q 2013-08-15
Q1 2013 183M +64.2M +53.9% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 161M +47.4M +41.6% Dec 31, 2012 10-K 2014-04-14
Q3 2012 141M +66.4M +88.8% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 129M +62.6M +94.5% Jun 30, 2012 10-Q/A 2013-01-22
Q1 2012 119M Mar 31, 2012 10-Q/A 2013-01-22
Q4 2011 114M +79.5M +231% Dec 31, 2011 10-K 2013-04-15
Q3 2011 74.7M Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 66.2M Jun 30, 2011 10-Q/A 2012-12-31
Q4 2010 34.4M Dec 31, 2010 10-K/A 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.